2017
DOI: 10.1590/abd1806-4841.20176016
|View full text |Cite
|
Sign up to set email alerts
|

S-100 negative myxoid neurothekeoma: a new type of neurothekeoma?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…It has been interesting to confirm that all previously mentioned histopathological features since 1980 when the terminology of NTK has been first introduced by Gallager and Helwig were still observed [1, 5]. Different reports have shown that NTK is consistently negative with S-100 in comparison to the NSM cases [6, 7]. Page in 2004 studied 11 cases to characterize the combination of MiTF and NKI/C3 expression in cellular NTK.…”
Section: Discussionmentioning
confidence: 89%
See 1 more Smart Citation
“…It has been interesting to confirm that all previously mentioned histopathological features since 1980 when the terminology of NTK has been first introduced by Gallager and Helwig were still observed [1, 5]. Different reports have shown that NTK is consistently negative with S-100 in comparison to the NSM cases [6, 7]. Page in 2004 studied 11 cases to characterize the combination of MiTF and NKI/C3 expression in cellular NTK.…”
Section: Discussionmentioning
confidence: 89%
“…IHC stains for NKI/C3 and CD-10 are useful ancillary tests for the diagnosis of cellular NTK if used in combination to histopathological features. Also, in cases of S-100 negative neurothekeoma of the myxoid type, fibro-histiocytic markers are to be considered such as CD-68 [6, 9, 10]. The differential diagnosis in the reviewed cases included neurothekeoma (23′) melanocytic tumor variants (especially a Spitz nevus), neurofibroma, schwannoma/neuroma variant, fibro-histiocytic tumor, and NSM.…”
Section: Discussionmentioning
confidence: 99%
“…NTKs were initially considered to be neurogenic tumours originating from Schwann cells, and NTKs were diagnosed and reported for many years as one of the subtypes of dermal nerve sheath myxomas[ 6 ]. Recently, studies have shown that, unlike DNSMs, NTKs do not express the S-100 protein[ 7 ]. Further analysis of gene expression profiles shows that DNSMs are similar to schwannomas, while NTKs show evidence of myofibroblastic differentiation and possible relation to dermatofibromas[ 8 ].…”
Section: Discussionmentioning
confidence: 99%